SECTION 8-ACCEPTED
accepted
on 27 Sep 2023
Last Applicant/ Owned by
855 N. Wolfe Street, Suite 621
Baltimore
MD
21205
Serial Number
87190457 filed on 01st Oct 2016
Registration Number
5320821 registered on 31st Oct 2017
Correspondent Address
Leonard D. Bowersox
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
ELIXIRGEN
Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others pharmaceutical preparations and substances for the treatment of telomere-shortening diseases (e.g., dyskeratosis congenita, Fanconi anemia, idiopathic and pulmonary fibrosis), k Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others
First Use Date in General
19th May 2016
First Use Date in Commerce
19th May 2016
Class [005]
Pharmaceutical Products
pharmaceutical preparations and substances for the treatment of telomere-shortening diseases (e.g., dyskeratosis congenita, Fanconi anemia, idiopathic and pulmonary fibrosis), karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, cancer; chemicals and chemical preparations for medical and pharmaceutical purposes for telomere-shortening diseases (e.g., dyskeratosis congenita, and Fanconi anemia), idiopathic pulmonary fibrosis, karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, and cancers
First Use Date in General
19th May 2016
First Use Date in Commerce
19th May 2016
Specimens
Mark Details
Serial Number
No 87190457
Mark Type
No Service Mark
Attorney Docket Number
No 3190-258
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.05.28 -
Miscellaneous designs with overall triangular shape
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Sep 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 27th Sep 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| 26th Sep 2023 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 23rd Aug 2023 | POST REGISTRATION ACTION MAILED - SEC. 8 |
| 22nd Aug 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 21st Mar 2023 | TEAS SECTION 8 RECEIVED |
| 17th Mar 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 17th Mar 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 17th Mar 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 17th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |